Radiopharm Theranostics Ltd (RADX) Short-term Investments (2024)
Radiopharm Theranostics' (RADX) quarterly Short-term Investments came in at $40000.0 in Q4 2024, up 15073.94% quarter-over-quarter from $263.61 in Q2 2024.
Analysis
Radiopharm Theranostics Ltd (RADX) Short-term Investments (2024) Analysis & Trends
Radiopharm Theranostics (RADX) has reported Short-term Investments for 1 consecutive years, with $40000.0 the latest figure, recorded in Q4 2024.
- On a quarterly basis, Short-term Investments changed N/A year-over-year to $40000.0 in Q4 2024; TTM through Dec 2024 was $40000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $40000.0, changed N/A from the prior year.
- Short-term Investments was $40000.0 for Q4 2024 at Radiopharm Theranostics, up from $263.61 in the prior quarter.
- Over five years, Short-term Investments peaked at $40000.0 in Q4 2024 and troughed at $263.61 in Q2 2024.
Peer Set